Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA grants orphan drug status to Soligenix’s dusquetide
The US Orphan Drug Act encourages the development of treatments for rare diseases affecting fewer than 200,000 people. Credit: Louis Reed on Unsplash.
The US Orphan Drug Act encourages the development of treatments for rare diseases affecting fewer than 200,000 people. Credit: Louis Reed on Unsplash.